Overview "Phospholipovit" vs Placebo in Patients With Combined Hyperlipidemia Status: Completed Trial end date: 2022-12-20 Target enrollment: Participant gender: Summary "Phospholipovit" vs placebo in patients with combined hyperlipidemia Phase: Phase 2/Phase 3 Details Lead Sponsor: Institute of Biomedical Chemistry, Russia